Surrogate endpoints: can size of effect mitigate perplexity?

Lancet Oncol. 2013 Jun;14(7):568-9. doi: 10.1016/S1470-2045(13)70196-7. Epub 2013 May 14.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biomarkers*
  • Carcinoma, Non-Small-Cell Lung / mortality*
  • Chemoradiotherapy / mortality*
  • Humans
  • Lung Neoplasms / mortality*

Substances

  • Biomarkers